Barlow Wealth Partners, Inc. Astrazeneca PLC Transaction History
Barlow Wealth Partners, Inc.
- $722 Billion
- Q2 2024
A detailed history of Barlow Wealth Partners, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Barlow Wealth Partners, Inc. holds 236,088 shares of AZN stock, worth $18.6 Million. This represents 2.61% of its overall portfolio holdings.
Number of Shares
236,088
Previous 143,421
64.61%
Holding current value
$18.6 Million
Previous $9.89 Billion
90.36%
% of portfolio
2.61%
Previous 1.35%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,333Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.11 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.35 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.19 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.89 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.38 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $244B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...